+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diagnostic Radiopharmaceuticals for Alzheimer Disease Market by Radiotracer Type, Radioisotope, End User, Application, Distribution Channel - Global Forecast to 2030- Product Image
Diagnostic Radiopharmaceuticals for Alzheimer Disease Market by Radiotracer Type, Radioisotope, End User, Application, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Diagnostic Radiopharmaceuticals for Alzheimer Disease Market by Radiotracer Type, Radioisotope, End User, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082406
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare decision-makers are navigating an evolving diagnostic radiopharmaceuticals market for Alzheimer’s disease, where technological advances, supply chain changes, and regulatory forces converge to redefine patient care and research opportunities.

Market Snapshot

The Alzheimer’s diagnostic radiopharmaceuticals market is shaped by the growing adoption of molecular imaging and the deployment of advanced radiotracers in clinical, research, and diagnostic settings. Adoption is influenced by expanding hospital networks, evolving reimbursement policies, and active clinical trial landscapes. Leading providers now leverage improved production infrastructure and broadened distribution to reach hospitals, diagnostic centers, and research laboratories. [ImageId=GUID] The competitive environment continues to develop as established imaging companies, biotechs, and startups refine multi-target tracer portfolios and integrate digital workflow solutions.

Scope & Segmentation

This report evaluates the diagnostic radiopharmaceuticals landscape for Alzheimer’s disease, focusing on supply chain factors, regional adoption trends, and segmentation drivers:

  • Radiotracer Types: Carbon-11 Pittsburgh Compound B; Fluorine-18 Florbetaben; Fluorine-18 Florbetapir; Fluorine-18 Flutemetamol
  • Radioisotopes: Carbon-11; Fluorine-18
  • End Users: Diagnostic centers; Hospitals; Research laboratories
  • Applications: Clinical imaging; Research imaging
  • Distribution Channels: Direct sales; Third-party distribution
  • Key Regions: Americas, including United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Profiles: Eli Lilly and Company, GE Healthcare Limited, Life Molecular Imaging, Inc., Bracco Imaging S.p.A., Fujifilm Holdings Corporation, Ion Beam Applications S.A., Curium Pharma, LLC, Navidea Biopharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc.

Key Takeaways

  • Fluorine-18 agents are increasingly favored due to their longer half-lives and expanded geographic reach, addressing key logistical and operational needs within clinical and research environments.
  • Industry adoption is accelerating with digital PET systems, AI-driven algorithms, and quantification software, which collectively improve resolution, standardization, and data-driven decision-making.
  • Regulatory acceptance and expanding reimbursement programs are driving widespread integration of amyloid PET imaging into dementia clinics, while the introduction of tau protein tracers supports development of multi-target diagnostic protocols.
  • Strategic collaborations between imaging conglomerates, biotech innovators, and academic startups are reshaping the competitive landscape, facilitating translation from pilot studies to scalable clinical solutions.
  • Participation in clinical trials and government initiatives is broadening tracer utilization, fostering holistic market development across regions with varied infrastructure maturity.

Assessing the 2025 US Tariffs’ Influence on Radiopharmaceutical Supply

The introduction of 2025 US tariffs has added complexity to the procurement of radiopharmaceuticals, particularly impacting precursor chemicals and specialized equipment. Carbon-11 precursor costs have risen, prompting manufacturers to adjust sourcing and supply chain strategies. Fluorine-18 production demonstrates resilience due to more established infrastructure and diversified sourcing. End users, such as hospitals and research labs, are responding through renegotiation, collaborative procurement, and the exploration of new distribution agreements. Industry stakeholders are minimizing exposure by relocating production, forming local alliances, and advocating for regulatory exemptions.

Methodology & Data Sources

Market insights were informed by primary interviews with industry leaders, clinical experts, and academic researchers, capturing operational, adoption, and regulatory perspectives. These insights were validated through a review of peer-reviewed literature, regulatory filings, production records, and clinical trial data. Triangulation and segment-based quantitative analysis ensured reliability throughout the findings.

Why This Report Matters

  • Strategic insight allows executives to anticipate market shifts and adapt sourcing, production, and R&D investments for sustained leadership.
  • Actionable segmentation and regional analysis support more informed pricing, partnership, and procurement decisions for evolving tracer portfolios.
  • Coverage of regulatory and logistical factors helps stakeholders mitigate risk and secure uninterrupted diagnostic radiopharmaceutical supply.

Conclusion

The diagnostic radiopharmaceutical market for Alzheimer’s disease is defined by innovation, operational adjustments, and increased collaboration. Forward-looking strategies centering on diversified supply, advanced technology adoption, and regional partnerships will drive future value and resilience.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Radiotracer Type
8.1. Introduction
8.2. Carbon 11 Pittsburgh Compound B
8.3. Fluorine 18 Florbetaben
8.4. Fluorine 18 Florbetapir
8.5. Fluorine 18 Flutemetamol
9. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Radioisotope
9.1. Introduction
9.2. Carbon 11
9.3. Fluorine 18
10. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals
10.4. Research Laboratories
11. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Application
11.1. Introduction
11.2. Clinical Imaging
11.3. Research Imaging
12. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Third Party Distribution
13. Americas Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Eli Lilly and Company
16.3.2. GE Healthcare Limited
16.3.3. Life Molecular Imaging, Inc.
16.3.4. Bracco Imaging S.p.A.
16.3.5. Fujifilm Holdings Corporation
16.3.6. Ion Beam Applications S.A.
16.3.7. Curium Pharma, LLC
16.3.8. Navidea Biopharmaceuticals, Inc.
16.3.9. Avid Radiopharmaceuticals, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET MULTI-CURRENCY
FIGURE 2. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET MULTI-LANGUAGE
FIGURE 3. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11 PITTSBURGH COMPOUND B, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETABEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETAPIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLUTEMETAMOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CLINICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY THIRD PARTY DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 73. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 74. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 83. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 84. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. NIGERIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 143. TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. POLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 159. POLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. POLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. POLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 174. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 179. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 184. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 234. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Diagnostic Radiopharmaceuticals for Alzheimer Disease market report include:
  • Eli Lilly and Company
  • GE Healthcare Limited
  • Life Molecular Imaging, Inc.
  • Bracco Imaging S.p.A.
  • Fujifilm Holdings Corporation
  • Ion Beam Applications S.A.
  • Curium Pharma, LLC
  • Navidea Biopharmaceuticals, Inc.
  • Avid Radiopharmaceuticals, Inc.

Related Topics

Related Reports

Diagnostic Radiopharmaceuticals Market by Product Type, Application, Radionuclide, End Use, Distribution Channel - Global Forecast to 2030 - Product Image

Diagnostic Radiopharmaceuticals Market by Product Type, Application, Radionuclide, End Use, Distribution Channel - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Radiopharmaceuticals in PET Imaging Market - A Global and Regional Analysis: Focus on Radioisotope Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035 - Product Image

Radiopharmaceuticals in PET Imaging Market - A Global and Regional Analysis: Focus on Radioisotope Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceuticals Market by Radioisotope Type, Delivery Format, Production Technology, Application, End User - Global Forecast to 2030 - Product Image

Radiopharmaceuticals Market by Radioisotope Type, Delivery Format, Production Technology, Application, End User - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.